Quanterix Corporation Business Acquisition, Pro Forma Net Income (Loss)
Quanterix Corporation (QTRX) reported Business Acquisition, Pro Forma Net Income (Loss) of -$135.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-03-02
- Quanterix Corporation business acquisition, pro forma net income (loss) for the quarter ending 2025-12-31 was $12.86M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for the quarter ending 2025-09-30 was -$34.11M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for the quarter ending 2024-12-31 was -$6.11M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for the quarter ending 2024-09-30 was -$24.37M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for fiscal 2025 was -$135.45M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for fiscal 2024 was -$96.92M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for fiscal 2019 was -$38.64M.
- Quanterix Corporation business acquisition, pro forma net income (loss) for fiscal 2018 was -$33.89M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$21.25M derived: sum of 2 quarters · filed 2026-03-02 | -$135.45M 10-K · filed 2026-03-02 | |
| 2025-09-30 | -$34.11M 10-Q · filed 2025-11-10 | -$148.31M 10-Q · filed 2025-11-10 | ||
| 2024-12-31 | -$6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$30.48M derived: sum of 2 quarters · filed 2026-03-02 | -$96.92M 10-K · filed 2026-03-02 | |
| 2024-09-30 | -$24.37M 10-Q · filed 2025-11-10 | -$90.81M 10-Q · filed 2025-11-10 | ||
| 2019-12-31 | -$10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$19.78M derived: sum of 2 quarters · filed 2022-03-01 | -$29.61M derived: sum of 3 quarters · filed 2022-03-01 | -$38.64M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$8.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$18.82M derived: sum of 2 quarters · filed 2020-11-06 | -$27.84M 10-Q · filed 2020-11-06 | -$37.52M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | -$9.83M 10-Q · filed 2020-08-04 | -$18.86M 10-Q · filed 2020-08-04 | -$28.53M derived: sum of 3 quarters · filed 2021-03-05 | -$36.43M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | -$9.06M 10-Q · filed 2020-05-07 | -$18.70M derived: sum of 2 quarters · filed 2021-03-05 | -$26.60M derived: sum of 3 quarters · filed 2021-03-05 | |
| 2018-12-31 | -$9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | -$17.54M derived: sum of 2 quarters · filed 2021-03-05 | -$33.89M 10-K · filed 2021-03-05 | |
| 2018-09-30 | -$7.90M 10-Q · filed 2019-11-08 | -$24.25M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |